Azenta Announces the Election of Dipal Doshi to its Board of Directors
Azenta, Inc. (Nasdaq: AZTA) today announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) ...
Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast
Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2025 earnings which ended on December 31, 2024, on Wednesday ...
Azenta: Taking A Pass
Azenta, Inc. shares have surged over 30% since Nov 2024 due to S&P 600 inclusion and an analyst upgrade, despite somewhat ...
Azenta elects Entrada CEO to Board of Directors
BURLINGTON, Mass. - Azenta, Inc. (NASDAQ: AZTA), a global provider of life sciences solutions, announced the election of ...
Azenta eyes streamlined focus, plans B Medical segment sale
Azenta, Inc. (NASDAQ:AZTA), a company specializing in special industry machinery with a market capitalization of $2.46 billion, announced today that it has classified its B Medical (TASE:PMCN) Systems ...
Nasdaq3d
Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable ...
DNA Synthesis Market Outlook 2024-2028: Global DNA Synthesis Market Set to Reach $6.52 Billion by 2028, Accelerating at 18.1% CAGR
The "DNA Synthesis Market 2024-2028" report has been added tAndMarkets.com's offering.The DNA synthesis market is forecasted to grow by USD 6.52 billion during 2023-2028, accelerating at a CAGR of 18.
Next-generation Sequencing (NGS) Market to Hit USD 22.38 Billion by 2029 with 11.0% CAGR | MarketsandMarkets
The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$ 13.28 ...